International Journal of Diabetes Mellitus
Volume 2, Issue 3 , Pages 189-195 , December 2010

Endothelial cell dysfunction in hyperglycemia: Phenotypic change, intracellular signaling modification, ultrastructural alteration, and potential clinical outcomes

  • Doina Popov

      Affiliations

    • Corresponding Author InformationAddress: Laboratory of Vascular Dysfunction in Diabetes and Obesity, Institute of Cellular Biology and Pathology “N. Simionescu” of the Romanian Academy, 8, B.P. Hasdeu Street, Bucharest 050568, Romania. Tel: +40 213194518; fax: +40 213194519.

Received 29 June 2010 ,Accepted 6 September 2010.

References 

  1. David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S, et al. Bone morphogenetic protein-9 is a vascular quiescence factor. Circ Res. 2008;102:914–922
  2. Herbert SP, Odell AF, Ponnambalam S, Walker JH. Activation of cytosolic phospholipase A2-α as a novel mechanism regulating endothelial cell cycle progression and angiogenesis. J Biol Chem. 2009;284:5784–5796
  3. Tanaka A, Itoh F, Nishiyama K, Takezawa T, Kurihara H, Itoh S, et al. Inhibition of endothelial cell activation by bHLH protein E2-2 and its impairment of angiogenesis. Blood. 2010;115:4138–4147
  4. Jiang A, Hu W, Meng H, Gao H, Qiao X. Loss of VLDL receptor activates retinal vascular endothelial cells and promotes angiogenesis. Invest Ophthalmol Vis Sci. 2009;50:844–850
  5. Sako K, Fukuhara S, Minami T, Hamakubo T, Song H, Kodama T, et al. Angiopoietin-1 induces Krüppel-like Factor 2 expression through a Phosphoinositide 3-Kinase/AKT-dependent activation of myocyte enhancer factor. J Biol Chem. 2009;284:5592–5601
  6. Singh H, Brindle NP, Zammit VA. High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1. Microvasc Res. 2010;79:121–127
  7. Fukuhara S, Sako K, Noda K, Zhang J, Minami M, Mochizuki N. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol. 2010;25:387–396
  8. Xu L, Komatsu M. Promoter cloning and characterization of the anti-vascular proliferation gene R-ras. Role of ETS- and SP-binding motifs. J Biol Chem. 2009;284:2706–2718
  9. Laughlin MH, Newcomer SC, Bender SB. Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype. J Appl Physiol. 2008;104:588–600
  10. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88:1322–1335
  11. Addabbo F, Montagnani M, Goligorsky MS. Mitochondria and reactive oxygen species. Hypertension. 2009;53:885–892
  12. Hirose A, Tanikawa T, Mori H, Okada Y, Tanaka Y. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS Lett. 2010;584:61–66
  13. Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem. 2009;16:94–112
  14. Nacci C, Tarquinio M, Montagnani M. Molecular and clinical aspects of endothelial dysfunction in diabetes. Intern Emerg Med. 2009;4:107–116
  15. Singh DK, Winocour P, Farrington K. Endothelial cell dysfunction, medial arterial calcification and osteoprotegerin in diabetes. Br J Diabetes Vasc Dis. 2010;10:71–77
  16. Highlander P, Shaw GP. Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics. Therap Adv Cardiovasc Dis. 2010;4:43–54
  17. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009;335:165–189
  18. Roy S, Trudeau K, Roy S, Behl Y, Dhar S, Chronopoulos A. New insights into hyperglycemia-induced molecular changes in microvascular cells. J Dental Res. 2010;89:116–127
  19. Van Geest RJ, Klaassen I, Vogels IM, Van Noorden CJ, Schlingemann RO. Differential TGF-β signaling in retinal vascular cells: a role in diabetic retinopathy?. Invest Ophthalmol Vis Sci. 2010;51:1857–1865
  20. Cherian S, Roy S, Pinheiro A, Roy S. Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats. Invest Ophthalmol Vis Sci. 2009;50:943–949
  21. McDonald DM, Coleman G, Bhatwadekar A, Gardiner TA, Stitt AW. Advanced glycation of the Arg–Gly–Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction. Mol Vis. 2009;15:1509–1520
  22. Martinez-Lemus LA, Hill MA, Meininger Gerald A. The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arteriolar diameter and structure. Physiology. 2009;4:45–57
  23. Rajapakse AG, Ming X-F, Carvas JM, Yang Z. The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects. Am J Physiol Heart Circ Physiol. 2009;296:H815–H822
  24. Liu Y, Biarnes M, Gerhardinger C. Effect of diabetes duration and high glucose on retinal Interleukin-1β expression. Invest Ophthalmol Vis Sci 2009;50:E-Abstract 4984.
  25. Bhatwadekar AD, Glenn JV, Curtis TM, Grant MB, Stitt AW, Gardiner TA. Retinal endothelial cell apoptosis stimulates recruitment of endothelial progenitor cells. Invest Ophthalmol Vis Sci. 2009;50:4967–4973
  26. Mzhavia N, Yu S, Ikeda S, Chu TT, Goldberg I, Dansky HM. Neuronatin: a new inflammation gene expressed on the aortic endothelium of diabetic mice. Diabetes. 2008;57:2774–2783
  27. Sarai K, Shikata K, Shikata Y, Omori K, Watanabe N, Sasaki M, et al. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins. Am J Physiol Cell Physiol. 2009;297:C945–C954
  28. Sheikh-Hamad D. Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endothelium. Am J Physiol Renal Physiol. 2010;298:F248–F254
  29. Sweet IR, Gilbert M, Maloney E, Hockenbery DM, Schwartz MW, Kim F. Endothelial inflammation induced by excess glucose is associated with cytosolic glucose 6-phosphate but not increased mitochondrial respiration. Diabetologia. 2009;52:921–931
  30. Zakkar M, Van der Heiden K, Luong LA, Chaudhury H, Cuhlmann S, Hamdulay SS, et al. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol. 2009;29:1851–1857
  31. Bucciarelli LG, Pollreisz A, Kebschull M, Ganda A, Kalea AZ, Hudson BI, et al. Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic mice. Diab Vasc Dis Res. 2009;6:249–261
  32. Huang Q, Sheibani N. High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am J Physiol Cell Physiol. 2008;295:C1647–C1657
  33. Borniquel S, García-Quintáns N, Valle I, Olmos Y, Wild B, Martínez-Granero F, et al. Inactivation of Foxo3a and subsequent downregulation of PGC-1α mediate Nitric Oxide-induced endothelial cell migration. Mol Cell Biol. 2010;30:4035–4044
  34. Hamed S, Brenner B, Abassi Z, Aharon A, Daoud D, Roguin A. Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in Type 2 Diabetes Mellitus. Thromb Res. 2010;126:166–174
  35. Azcutia V, Abu-Taha M, Romacho T, Vazquez-Bella M, Matesanz N, Luscinskas FW, et al. Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo. PLoS One. 2010;5:e10091
  36. Perrone L, Devi TS, Hosoya K-I, Terasaki T, Singh LP. Thioredoxin Interacting Protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol. 2009;221:262–272
  37. Zitman-Gal T, Green J, Pasmanik-Chor M, Oron-Karni V, Bernheim J. Endothelial pro-atherosclerotic response to extracellular diabetic-like environment: possible role of thioredoxin-interacting protein. Nephrol Dial Transplant. 2010;25:2141–2149
  38. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009;94:3171–3182
  39. Stegenga ME, van der Crabben SN, Blümer RME, Levi M, Meijers JCM, Serlie MJ, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008;112:82–89
  40. Molins B, Peña E, Padro T, Casani L, Mendieta C, Badimon L. Glucose-Regulated Protein 78 and platelet deposition: effect of Rosuvastatin. Arterioscler Thromb Vasc Biol. 2010;30:1246–1252
  41. Borradaile NM, Pickering JG. Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment. Aging Cell. 2009;8:100–112
  42. Takamura Y, Tomomatsu T, Kubo E, Tsuzuki S, Akagi Y. Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells. Invest Ophthalmol Vis Sci. 2008;49:3216–3223
  43. Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, Chen L, et al. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol. 2003;81:177–199
  44. Zanetti M, Stocca A, Dapas B, Farra R, Uxa L, Bosutti A, et al. Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose. J Mol Med. 2008;86:185–195
  45. Chen G, Shen X, Yao J, Chen F, Lin X, Qiao Y, et al. Ablation of NF-kappaB expression by small interference RNA prevents the dysfunction of human umbilical vein endothelial cells induced by high glucose. Endocrine. 2009;35:63–74
  46. Wang S, Hirschberg R. Diabetes-relevant regulation of cultured blood outgrowth endothelial cells. Microvasc Res. 2009;78:174–179
  47. Chao CL, Hou YC, Chao PD, Weng CS, Ho FM. The antioxidant effects of quercetin metabolites on the prevention of high glucose-induced apoptosis of human umbilical vein endothelial cells. Br J Nutr. 2009;101:1165–1170
  48. Li A-F, Roy S. High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2009;50:1400–1407
  49. Hou CJ-Y, Tsai C-H, Su C-H, Wu Y-J, Chen S-J, Chiu J-J, et al. Diabetes reduces aortic endothelial gap junctions in ApoE-deficient mice: simvastatin exacerbates the reduction. J Histochem Cytochem. 2008;56:745–752
  50. Zimering MB, Pan Z. Autoantibodies in Type 2 diabetes induce stress fiber formation and apoptosis in endothelial cells. J Clin Endocrinol Metab. 2009;94:2171–2177
  51. Trudeau K, Molina A, Roy S. High glucose alters mitochondrial morphology and membrane potential heterogeneity in retinal endothelial cells. Invest Ophthalmol Vis Sci. 2009;50:E-Abstract 33/A20
  52. Patti M-E, Corvera S. The role of mitochondria in the pathogenesis of Type 2 diabetes. Endocr Rev. 2010;31:364–395
  53. Zhong W, Zou G, Gu J, Zhang J. l-arginine attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells. Diabetes Res Clin Pract. 2010;89:38–45
  54. Erusalimsky JD. Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol. 2009;106:326–332
  55. Orimo M, Minamino T, Miyauchi H, Tateno K, Okada S, Moriya J, et al. Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol. 2009;29:889–894
  56. Dabir P, Marinic TE, Krukovets I, Stenina OI. Aryl Hydrocarbon Receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells. Circ Res. 2008;102:1558–1565
  57. Chen S, Feng B, George B, Chakrabarti R, Chen M, Chakrabarti S. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am J Physiol Endocrinol Metab. 2010;298:E127–E137
  58. Brunssen C, Korten S, Brux M, Seifert S, Roesler J, Bornstein SR, et al. COUP-TFII is regulated by high glucose in endothelial cells. Horm Metab Res. 2010;42:81–87
  59. Seeger FH, Chen L, Spyridopoulos I, Altschmied J, Aicher A, Haendeler J. Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells. PLoS One. 2009;4(2):e4529
  60. Tanaka J, Qiang L, Banks AS, Welch CL, Matsumoto M, Kitamura T, et al. Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells. Diabetes. 2009;58:2344–2354
  61. Behl Y, Krothapalli P, Tesfahun D, Roy S, Graves DT. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in Type 1 and Type 2 diabetic rats. Diabetes. 2009;58:917–925
  62. Zheng Z, Chen H, Zhao H, Liu K, Luo D, Chen Y, et al. Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro. Invest Ophthalmol Vis Sci. 2010;51:64–71
  63. Xie Z, Zhang J, Wu J, Viollet B, Zhou M-H. Upregulation of mitochondrial Uncoupling Protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes. 2008;57:3222–3230
  64. Geraldes P, King GL. Activation of Protein Kinase C isoforms and its impact on diabetic complications. Circ Res. 2010;106:1319–1331
  65. Banumathi E, Sheikpranbabu S, Haribalaganesh R, Gurunathan S. PEDF prevents reactive oxygen species generation and retinal endothelial cell damage at high glucose levels. Exp Eye Res. 2010;90:89–96
  66. Brouwers O, Niessen PM, Haenen G, Miyata T, Brownlee M, Stehouwer CD, et al. Hyperglycemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia. 2010;53:989–1000
  67. Min Q, Bai YT, Jia G, Wu J, Xiang JZ. High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells. Exp Mol Pathol. 2010;88:133–137
  68. Caporali A, Pani E, Horrevoets AJG, Kraenkel N, Oikawa A, Sala-Newby GB, et al. Neurotrophin p75 Receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis. Implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res. 2008;103:e15–e26
  69. Bishara NB, Ding H. Glucose enhances expression of TRPC1 and calcium entry in endothelial cells. Am J Physiol Heart Circ Physiol. 2010;298:H171–H178
  70. Mahrouf-Yorgov M, Marie N, Borderie D, Djelidi R, Bonnefont-Rousselot D, Legrand A, et al. Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells. Metabolism. 2009;58:525–533
  71. Wang S, Peng Q, Zhang J, Liu L. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain. Cardiovasc Res. 2008;80:255–262
  72. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009;196:193–222
  73. Cai W, He JC, Zhu L, Chen X, Striker GE, Vlassara H. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. Am J Physiol Cell Physiol. 2008;294:C145–C152
  74. Jaimes EA, Hua P, Tian R-X, Raij L. Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol. 2010;298:F125–F132
  75. Mohan S, Konopinski R, Yan B, Centonze VE, Natarajan M. High glucose-induced IKK–Hsp-90 interaction contributes to endothelial dysfunction. Am J Physiol Cell Physiol. 2009;296:C182–C192
  76. Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells. Atherosclerosis. 2010;209:66–73
  77. Ruderman Neil B, Julia Xu X, Nelson Lauren, Cacicedo José M, Saha Asish K, Lan Fan, et al. AMPK and SIRTI: a long-standing partnership?. Am J Physiol Endocrinol Metab. 2010;298:E751–E760
  78. Addabbo F, Ratliff B, Park H-C, Kuo M-C, Ungvari Z, Ciszar A, et al. The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction. Proteomic approach. Am J Pathol. 2009;174:34–43
  79. Simionescu M, Popov D, Sima A. Endothelial dysfunction in diabetes. In:  Cheta DM editors. Vascular involvement in diabetes: clinical, experimental and beyond. Bucharest: Karger and the Publishing House of the Romanian Academy; 2004;p. 15–34
  80. Simionescu M, Popov D, Sima A, Hasu M, Costache G, Faitar S, et al. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model: the hyperlipemic hyperglycemic hamster. Am J Pathol. 1996;148:997–1014
  81. Popov D, Simionescu M. Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium. Arch Physiol Biochem. 2006;112:265–273
  82. Popov D. Towards understanding the mechanisms of impeded vascular function in the diabetic kidney. In:  Simionescu M,  Sima A,  Popov D editor. Cellular dysfunction in atherosclerosis and diabetes – reports from bench to bedside. Bucharest: The Publishing House of the Romanian Academy; 2004;p. 244–259
  83. Estrella JS, Nelson RN, Sturges BK, Vernau KM, Williams DC, LeCouteur RA, et al. Endoneurial microvascular pathology in feline diabetic neuropathy. Microvasc Res. 2008;75:403–410
  84. Dokken BB. The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectrum. 2008;21:160–165
  85. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, Thornalley PJ. Activation of NF-E2-Related Factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes. 2008;57:2809–2817
  86. Torreggiani M, Liu H, Wu J, Zheng F, Cai W, Striker G, et al. Advanced Glycation End Product Receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. Am J Pathol. 2009;175:1722–1732
  87. Won JC, Park J-Y, Kim YM, Koh EH, Seol S, Jeon BH, et al. Peroxisome Proliferator-Activated Receptor-γ Coactivator 1-α overexpression prevents endothelial apoptosis by increasing ATP/ADP translocase activity. Arterioscler Thromb Vasc Biol. 2010;30:290–297
  88. Wang S, Xu J, Song P, Viollet B, Zou M-H. In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP Cyclohydrolase I. Diabetes. 2009;58:1893–1901
  89. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med. 2009;11:e19
  90. Ramirez SH, Fan S, Zhang M, Papugani A, Reichenbach N, Dykstra H, et al. Inhibition of Glycogen Synthase Kinase 3β (GSK3β) decreases inflammatory responses in brain endothelial cells. Am J Pathol. 2010;176:881–892
  91. Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, Gragoudas ES. Role of 4 Integrin (CD49d) in the pathogenesis of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50:4898–4904
  92. Whetzel AM, Bolick DT, Hedrick CC. Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3. Am J Physiol Cell Physiol. 2009;296:C339–C345
  93. Ray BN, Lee NY, How T, Blobe GC. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. Carcinogenesis. 2010;31:435–441
  94. Tang Y, Scheef EA, Wang S, Sorenson CM, Marcus CB, Jefcoate CR, et al. CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. Blood. 2009;113:744–754
  95. Li Y, Wu H, Khardori R, Song YH, Lu YW, Geng YJ. Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis. Biochem Biophys Res Commun. 2009;384:259–264

PII: S1877-5934(10)00071-8

doi: 10.1016/j.ijdm.2010.09.002

International Journal of Diabetes Mellitus
Volume 2, Issue 3 , Pages 189-195 , December 2010

Article Tools

* Image Usage & Resolution